Agios Pharmaceuticals | AGIO - Lngresos Netos





Lngresos Netos Cambio Fecha
AbbVie USD 3.61B 2.92B 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Eli Lilly USD 7.4B 760M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 435M 1.3B 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.26B 108M 2026-06
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03